Barclays plans phoenix autocallables linked to Bristol-Myers Squibb

By Wendy Van Sickle

Columbus, Ohio, Oct. 19 – Barclays Bank plc plans to price phoenix autocallable notes due Oct. 25, 2018 linked to the common stock of Bristol-Myers Squibb Co., according to a 424B2 filing with the Securities and Exchange Commission.

The notes will pay a contingent quarterly coupon at an annual rate of 10.5% if the stock closes at or above its barrier level, 75% of its initial level, on the observation date for that period.

The notes will be called at par plus the contingent coupon if the stock closes at or above its initial level on any observation date beginning other than the final date.

The payout at maturity will be par plus the contingent coupon unless the stock finishes below its barrier level, in which case investors will be fully exposed to any losses.

Barclays is the agent.

The notes will price on Oct. 21 and settle on Oct. 26.

The Cusip number is 06741VDD1.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.